This is a distressed micro-cap using massive share issuance to meet a new Nasdaq listing standard — not a growth catalyst. The 597% dilution is extreme for a $3M market cap company. Monitor for Nasdaq compliance confirmation and watch for further dilutive financing needs. The stock is highly susceptible to further downside pressure from the overhang of unregistered shares that may be registered for resale.
Price Chart
Executive Summary
Healthcare Triangle issued 12,546,540 shares of common stock on July 28, 2026, to close two legacy M&A transactions: the Teyame AI acquisition and the SecureKloud Technologies share exchange. This massive 597% dilution (from ~2.1M to 14.6M shares outstanding) was done to boost the company's market value of listed securities to ~$23.9M, providing cushion under Nasdaq's new $5M MVLS continued listing standard. The stock closed at $1.63 on the issuance date, giving the company a $3M market cap — the dilution is extreme and the compliance narrative is defensive, not growth-oriented.
Key Financial Metrics
Key Facts
- Issued 12,546,540 shares of common stock on July 28, 2026
- Shares issued to close Teyame AI acquisition (9,718,373 shares) and SecureKloud Technologies share exchange (2,828,167 shares)
- Total shares outstanding increased to 14,644,322 from approximately 2,097,782 (pre-issuance)
- Market Value of Listed Securities was approximately $23,870,244 based on $1.63 closing price on July 28, 2026
- Nasdaq's new $5M MVLS continued listing standard was approved by the SEC on July 22, 2026
- Company market cap is approximately $3M — extreme dilution relative to market cap
Financial Impact
Issued 12,546,540 shares representing approximately 597% dilution to pre-issuance share count. No cash proceeds raised — shares issued for non-cash M&A consideration.
Risk Factors
- Extreme 597% dilution to existing shareholders
- No cash proceeds raised — shares issued for non-cash M&A consideration
- Nasdaq compliance not yet confirmed — company explicitly states this press release does not constitute confirmation from Nasdaq
- Unregistered shares may be registered for resale, creating further overhang
- Company has $3M market cap — highly speculative and volatile
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-082514 |
| Document: ea029955101ex99-1.htm | 0001213900-26-082514 |
| Document: 0001213900-26-082514-index-headers.html | 0001213900-26-082514 |
| Document: 0001213900-26-082514-index.html | 0001213900-26-082514 |
| Document: 0001213900-26-082514.txt | 0001213900-26-082514 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | DEF 14A | $0.3820 | awaiting T+20 | — | — |
Oct 2, 2026 23d ago | 8-K | $0.6069 | awaiting T+20 | — | — |
Oct 1, 2026 25d ago | EFFECT | $0.7016 | awaiting T+20 | — | — |
Aug 13, 2026 10w ago | Press Release | $1.73 $0.7457 | ▲ +56.90% | ▲ +55.15% | — |
Jul 29, 2026 12w ago | 8-K | $1.56 $0.8683 | ▲ +44.34% | ▲ +49.36% | — |
Jul 27, 2026 13w ago | Press Release | $1.70 $0.8446 | ▼ −50.32% | ▼ −53.62% | — |
Jul 16, 2026 14w ago | EFFECT | $1.89 $1.73 | ▲ +8.47% | ▲ +12.08% | — |
Jun 26, 2026 17w ago | 8-K | $1.88 $1.62 | ▲ +13.83% | ▲ +13.55% | — |
Jun 15, 2026 18w ago | 8-K | $2.30 $1.74 | ▲ +24.35% | ▲ +24.55% | — |
Apr 16, 2026 27w ago | 10-K/A | $2.47 $2.28 | ▲ +7.69% | ▲ +13.06% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers